Skip to Main Content

Paper Details

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Blood
304
2017
CLL, Chronic lymphocytic leukemia, PD-, PD-1, PD-L1, PD-ligand 1, Pembrolizumab, RT, Richter transformation, diffuse large cell lymphoma, humanized, humanized PD-1-blocking antibody, ibrutinib, patients, pembrolizumab, programmed death 1, tumor, tumor specimens

Datasets

Release 1.2